Correction to: Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab
- 346 Downloads
1 Correction to: Drugs https://doi.org/10.1007/s40265-018-0922-6
The legend, which reads
Mechanisms of action of monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
TFPI mechanism of action and inhibition by anti-TFPI antibodies. a Tissue factor (TF) based initiation of coagulation and generation of FXa by the extrinsic tenase complex (FVIIa.TF.FX). b Inhibition of FXa and FVIIa by TFPI. c Binding of the different Kunitz (K) domains by the various anti-TFPI antibodies.
The original article has been corrected.